Pfizer Earnings Beat Estimates

As investor worries heightened last year over Covid-19 products’ waning demand, the company is taking steps to rev up sales including launching new ventures such as new drugs and vaccine approvals.
Source: Reuters: Health - Category: Consumer Health News Source Type: news